Skip to content

Clinical Course and Treatment of COVID-19 Inpatients in Hospital

Clinical Course and Treatment of COVID-19 Inpatients in Hospital

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04527497
Enrollment
35
Registered
2020-08-26
Start date
2020-08-01
Completion date
2021-08-31
Last updated
2023-12-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COVID-19

Brief summary

The study is an epidemiological observational study. It serves to collect data from patients with positive COVID-19 test results who are hospitalized. All data describing the course of the inpatient stay are recorded (Length of stay, course of therapy, medication, X-ray and CT results,ventilation mode and duration, laboratory). Furthermore, anthropometric data and information on COVID-19 symptoms is recorded.

Detailed description

The aim of this study is to describe the course of disease and the treatment of patients suffering from COVID-19 who are hospitalized and treated as inpatients: 1. Are there common features (previous illnesses, medication, age, BMI, etc.), which may influence the course of disease? 2. Are there therapeutic procedures that have a positive or negative impact on the course of the disease or the length of stay in the intensive care unit/ the duration of ventilation (early/late intubation, CPAP, NIV, ECMO)?

Interventions

None listed

Sponsors

Wissenschaftliches Institut Bethanien e.V
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum

Inclusion criteria

* positive COVID-19 test result * Age \> 18 years

Exclusion criteria

* Age \< 18 years * negative COVID-19 test result * lack of agreement * Any medical, psychological or other condition, that restricts the ability of the person to be informed and to give the consent for voluntary participation in this trial

Design outcomes

Primary

MeasureTime frameDescription
convalescence/deaththrough study completion, an average of 2 monthshas patient died or has patient recovered

Secondary

MeasureTime frameDescription
length of stay in the intensive care unitthrough study completion, an average of 2 monthslength of stay in the intensive care unit
length of stay in hospitalthrough study completion, an average of 2 monthslength of stay in hospital

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026